The reference listed drugs selected by China National Medical Products Administration (NMPA) are reference products to which generic drugs should be equivalent in quality and therapeutic efficacy.
Related resource: Generic Drug Registration Application (ANDA) in China
| No. | Drug Name | Dosage Form | Brand Name | Strength | MAH | Note 1 | Note 2 | Batch |
| 77-13 | view | view | EXTENCILLINE | view | Laboratoires Delbert | Original drug not imported to China | Approved in EU | The 77th Batch of Reference Listed Drugs |
| 77-14 | view | view | EXTENCILLINE | view | Laboratoires Delbert | Original drug not imported to China | Approved in EU | The 77th Batch of Reference Listed Drugs |
| 77-15 | view | view | / | view | Siga Technologies Inc. | Original drug not imported to China | US Orange Book | The 77th Batch of Reference Listed Drugs |
| 77-16 | view | view | / | view | Siga Technologies Nehterlands B.V. | Original drug not imported to China | Approved in EU | The 77th Batch of Reference Listed Drugs |
| 77-17 | view | view | Tabrecta | view | Novartis Europharm Limited | Original drug not imported to China | Approved in EU | The 77th Batch of Reference Listed Drugs |
| 77-18 | view | view | Tabrecta | view | Novartis Europharm Limited | Original drug not imported to China | Approved in EU | The 77th Batch of Reference Listed Drugs |
| 77-19 | view | view | Nephrotect | view | Fresenius Kabi | / | Approved in EU | The 77th Batch of Reference Listed Drugs |
| 77-20 | view | view | ALFAROL | view | Chugai Pharmaceutical Co., Ltd. (中外製薬株式会社) | Original drug not imported to China | Approved in Japan | The 77th Batch of Reference Listed Drugs |
| 77-21 | view | view | / | view | Daiichi Sankyo Co., Ltd. (第一三共株式会社) | Original drug not imported to China | Approved in Japan | The 77th Batch of Reference Listed Drugs |
| 77-22 | view | view | / | view | Daiichi Sankyo Co., Ltd. (第一三共株式会社) | Original drug not imported to China | Approved in Japan | The 77th Batch of Reference Listed Drugs |
